CLDN5 and cholangiocarcinoma: To investigate the underlying mechanisms by which senescent endothelial cells promote the CCA in primary liver cancer, RH-35 rat hepatocellular carcinoma cells were used to co-culture with the CD34+CLDN5+ ECs for 6 days.